578:. The company had entered into an exclusive agreement with Profarmica, an Italian company that supplied drug ingredients, after which the company's competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs. Before the round of price increases the price of generic drugs had been 5 - 10% of the price of branded drugs and afterwards it was around 50%. The FTC filed suit at the end of 1998 and 32 states filed parallel actions. The case was settled in 2000, with the company paying a total of $ 147M -- $ 100M in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid, $ 8 million in attorney's fees to the State Attorneys General, $ 35 million, plus $ 4 million in attorney's fees, to settle certain class actions with insurers and managed care organizations—and Mylan and three ingredient suppliers (
1120:. The last price increase coincided with the company's airing of a new line of TV commercials that were described as "shocking" and "no holds barred", depicting an anaphylactic reaction from the point of view of the young woman having it at a party, and ending with the young woman seeing her swollen and hive-covered face in the mirror before she collapses. In response to criticism, the company increased financial assistance available for some patients to purchase EpiPens, a gesture that was called a "classic public relations move" by Harvard Medical School professor Aaron Kesselheim. The up to $ 300 saving cards can only be used by a small number of people who need the drug, and no one on
512:
compared with
Dyazide's 25 mg hydrochlorothiazide and 50 mg triamterene). This drug had to get approval as a new drug, as opposed to a generic. Their product was called Maxzide and was approved in 1984. The higher dose allowed once per day dosing, which the company and its marketing partner, Lederle, believed would help it compete against Dyazide, which had $ 210M in sales in 1983. However, the company's patents on the drug were declared invalid in court, and its marketing exclusivity expired in 1987, prompting a rush of generic competition.
230:
4335:
40:
1998:
3153:"Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to all Lots Within Expiry Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient"
504:; it had been on the market since 1965 and its patents had expired in 1980. Complications arose with the introductions of generics versions, because the formulation of Dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent.
1181:
criticized the company for the "outsized compensation" of its directors. Former CEO Robert Coury received a $ 98 million 2016 pay package in spite of shareholder losses and the perceived harm to the company inflicted by the EpiPen controversies. The report urged the company's shareholders to oust all
705:
After successful lobbying from the company, in 2013, the "School Access to
Emergency Epinephrine Act" became law after passing Congress with broad and bipartisan support; it protected anyone from liability if they administered epinephrine to a child in a school (previously, only trained professionals
698:, the mother of the company's CEO, Heather Bresch, had become president of the association in 2010, and shortly after had discussed donations from her "daughter's company" to the association. Manchin had been appointed to the West Virginia state school board by her husband, then-governor of the state
515:
The company had concerns about the practices of its competitors and the FDA in general, and also with regard to companies seeking to bring generic versions of
Maxzide. The company hired private investigators to examine its competitors' practices, and when it found evidence of corruption, it submitted
1160:
involves misclassifying proprietary drugs as generic under the program. Under the agreement, the company agreed to pay a $ 465 million payment and to sign a corporate integrity agreement requiring it to perform better in the future; the settlement also resolved cases brought by states related to the
693:
launched a policy initiative designed to "help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine auto-injector access and use," and advocated for state laws protecting schools from legal liability for stocking and using epinephrine autoinjectors.
604:
obtaining a 9.8% interest in Mylan and becoming its largest stakeholder in order to kill the deal. The parties called off the deal in
February 2005. Afterwards, Icahn offered to buy Mylan for $ 5.4 billion and nominated a slate of board members to change the direction of Mylan; he won three seats in
531:
The corruption in the nascent generics industry and at the office in the FDA regulating it was widely covered in the media, and led to widespread concern among doctors and the public in the late 1980s and early 1990s that generic drugs were not really the same as the branded drugs they were meant to
1155:
over rebates paid by the company to states under the
Medicaid Drug Rebate Program. Questions had been raised by Congress and others about why EpiPen had been classified as a generic rather a proprietary product in the program since 1997; generic drugs have lower rebates (13%) than proprietary drugs
1150:
According to the
Department of Health and Human Services' Office of Inspector General analysis, the U.S. government may have overpaid "as much as $ 1.27 billion between 2006 and 2016" to the company for the EpiPen emergency allergy treatment. This represents three times the proposed settlement of $
1146:
In
October 2016, the CEO of the company testified to Congress that Pfizer/King charged the company about $ 34.50 for one device. In September 2016, a Silicon Valley engineering consultancy performed a teardown analysis of the EpiPen and estimated the manufacturing and packaging costs at about $ 10
507:
Some generic companies committed fraud trying to bring a generic version of
Dyazide. Bolar Pharmaceutical had the first generic version approved in 1987, but it turned out that Bolar had fraudulently substituted Dyazide for its own version to conduct studies that were submitted to the FDA. By 1989
1107:
reported that Bresch provided similarly dismissive responses. The reporter noted that "Those top leaders’ responses are a far cry from the message on Mylan’s website, which says that 'we challenge every member of every team to challenge the status quo,' and that 'we put people and patients first,
1102:
reported that when these concerns were brought to Robert Coury, the chairman of the board, Coury "replied that he was untroubled. He raised both his middle fingers and explained, using colorful language, that anyone criticizing Mylan, including its employees, ought to go copulate with themselves.
1074:
for people with severe allergies that made the brand "EpiPen" as identified with its product as "Kleenex" is with facial tissue. The company also successfully lobbied the FDA to broaden the label to include risk of anaphylaxis and in parallel, successfully lobbied
Congress to generate legislation
511:
The company chose to develop a new version of a triamterene/hydrochlorothiazide combination drug instead of going the generic route; it developed a different, more stable formulation and used different dosages of each active ingredient (50 mg hydrochlorothiazide and 75 mg triamterene,
1090:
By the first half of 2015, Mylan had an 85% market share of such devices in the US and in that year sales reached around $ 1.5 billion and accounted for 40% of Mylan's profit. Those profits were also due in part to Mylan's continually raising the price of EpiPens starting in 2009; in 2009 the
636:
after the newspaper ran an article that was critical of the quality control procedures used at the company's
Morgantown plant. The company had earlier quality control issues involving the FDA. The lawsuits were dropped in 2012 without any damages paid by the Post-Gazette, which stated "The
702:, in 2007. In a statement, the company said, "There is no truth to the suggestion that the company's efforts were anything but straightforward or that we are aware of anyone advocating inappropriately for the right of schoolchildren to have access to potential life-saving medicine."
599:
began discussing a deal in which Mylan would acquire King for $ 4 billion; Mylan wanted to expand its presence in branded pharmaceuticals and to acquire King's sales force. The deal was complicated by a number of factors, and included an SEC investigation into King's accounting and
1070:, the devices deliver about $ 1 worth of drug. At that time annual sales were around $ 200 million. Bresch, the company's CEO, saw an opportunity to increase sales through marketing and advocacy, and the company launched a marketing campaign to increase awareness of the dangers of
673:(US)/Seretide (UK) Diskus incorporating Pfizer's proprietary dry powder inhaler delivery platform. The company launched the product in the UK in 2015 and in February 2016 the FDA accepted its ANDA, putting it in line behind Hikma and Sandoz to launch a generic version in the US.
1124:. They do nothing about the high price, he said, which is still being paid by insurers, who ultimately pass the cost onto consumers. The company further responded by releasing the first authorized generic version of the EpiPen in December 2016 at a more than 50% discount.
805:
In October 2017, the company announced the launch of the first FDA-approved generic of Teva’s long-acting Copaxone. Approximately three months later, Credit Suisse analyst Vamil Divan cited IMS Health data which showed that the new generic accounted for 10% of the market.
685:
to sell EpiPens in bulk and with discounts to schools. To participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year, a requirement which a company spokesperson said is no longer part of its program.
1111:
In the summer of 2016, as parents prepared to send their children back to school and went to pharmacies to get new EpiPens, people began to express outrage at the cost of the EpiPen and the company was widely and harshly criticized, including criticism from
617:, for approximately $ 736 million, with the takeover including all of Matrix's subsidiary firms, for example Docpharma. It was at the time the largest-ever takeover in the Indian pharma industry and also gave access to markets in China, India, and Africa.
1202:. European manufacturers refuse to sell drugs which can be used for executions to the United States, except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain.
648:. The program requires drug companies to give rebates to states under Medicaid and the rebates are higher for new drugs than for generics; the suit said that the companies sold new drugs but paid rebates as if they were generics.
1240:
itself of $ 70 million in Mylan shares for that reason. The company said that its distribution was "legally compliant," and that their restrictions did "prohibit resale to correctional facilities for use in lethal injections."
762:
offered to buy the company for $ 40 billion; the combined companies would have been the world's largest generic company and the 9th biggest drug company in the world. In July, Teva dropped its bid for Mylan and instead acquired
4182:
1986:
3991:
1098:, mid-level executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the Epi-Pen, and raising concerns that the price increases were unethical; the
1091:
wholesale price of two EpiPens was about $ 100, by July 2013 the price was about $ 265, in May 2015 it was around $ 461, and in May 2016 the price rose again to around $ 609, around a 500% jump from the price in 2009.
706:
or the affected person were allowed to administer the drug, and were open to liability), and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them.
1225:
without legal controls in place to prevent its use in executions, and there was "a very real risk that Mylan may soon become the go-to provider of execution drugs for states across the country". German asset manager
459:
Panoz left the company in 1969 and Puskar quit the company in 1973, as it grew and experienced financial difficulties. The board hired Roy McKnight as board chairman, who convinced Puskar to return in 1976.
1103:
Critics in Congress and on Wall Street, he said, should do the same. And regulators at the Food and Drug Administration? They, too, deserved a round of anatomically challenging self-fulfillment." The
528:, were targets of the company's initial investigation and were found to have used Maxzide to obtain their bioequivalence data, leading both companies to withdraw its generic competitor to Mylan's product.
718:
In 2013, the company acquired an Indian generic injectable drugs company, Agila Specialties Private, for $ 1.6 billion. In 2015, three plants acquired in that deal were issued warning letters by the FDA.
3152:
479:
in 1984, the company and other small generic companies gained value; in the eighteen months following passage of the law the company's earnings grew 166% to $ 12.5 million and its stock value rose 800%.
540:
In 1987, the company entered into a joint venture with Bolar to buy Somerset Pharmaceuticals; Mylan wanted access to Somersets' drug discovery capabilities as well as its new drug for Parkinson's,
2857:
2818:
4381:
637:
Post-Gazette did not find and did not intend to report that Mylan had manufactured or distributed any defective drugs. The Post-Gazette regrets if any reader of the article thought otherwise."
517:
4107:
629:
for $ 6.6 billion. The company acquired the rights to market the EpiPen in the transaction. At that time annual sales were around $ 200 million and the EpiPen had about 90% of the market.
2374:
798:
of 20 states filed a civil complaint accusing the company of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug. The complaint alleged
1108:
trusting that profits will follow'", and also noted that "The firm is a case study in the limits of what consumer and employee activism, as well as government oversight, can achieve."
3242:
5203:
750:, offering to buy $ 26 billion in shares directly from shareholders. Too few shareholders agreed to sell their stock by the deadline set in November 2015 and the effort failed.
2918:
5163:
556:
technologies, and kept it as a subsidiary. In 1999, the company renamed Bertek as Mylan Technologies Inc. (MTI). MTI eventually came to be the contract manufacturer for the
3848:
1116:, "poster boy for grasping pharma greed," letters from two senators and initiation of Congressional investigations. Mylan's pricing of the EpiPen was widely referred to as
524:'s generic drugs division and at other generic companies. Two of the companies that had gotten approval to market generic versions of Maxzide, Vitarine Pharmaceutical and
5223:
4374:
1371:
Heather Bresch was an Executive Director and the CEO of Mylan from 2012 until the Viatris combination in 2020. Robert Coury was Chairman, and Rajiv Malik was President.
2437:
2616:
5173:
2733:
2648:
863:. The company continued sales of Mylan's more than 7,500 products, including biosimilars, generics, brand and over-the-counter remedies, with brands including the
2575:
4390:
4367:
476:
3620:
5168:
738:
Also in February 2015, the company acquired Mumbai-based Famy Care and expand its presence in the market for women's contraceptives at about $ 750 million.
5228:
5198:
4183:"MYLAN's MAXZIDE IS "APPROVABLE" AT FDA: LEDERLE TO MARKET BRAND COMPETITION TO SMITHKLINE's No. 3-RANKED DYAZIDE; FINAL APPROVAL ANTICIPATED "IMMINENTLY""
775:
In June 2015, the company agreed to work with Pulmatrix, a company with a proprietary inhaled drug delivery platform, to co-develop a product to treat for
582:, Profarmaco S.R.L., and Gyma Laboratories) also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future.
4872:
4862:
4852:
4842:
4832:
4822:
4812:
4802:
4792:
809:
In May 2018, the company announced a collaboration with West Virginia University to expose children across West Virginia to STEM educational initiatives.
3743:
1987:
Mylan's Maxzide is "Approvable" at FDA: Lederle To Market Brand Competition to Smithkline's No. 3-Ranked Dyazide; Final Approval Anticipated "Imminently"
3213:
3408:
3263:
2211:
3898:
2690:
1632:
690:
4208:
3536:
2899:
2516:
2096:
1940:
791:
for $ 9.9 billion. In May 2016, the company announced it would acquire Renaissance Acquisition Holdings dermatology division for up to $ 1 billion.
5208:
5183:
4302:
3445:
1477:
3808:
1064:
devices from Merck KGaA as part of their 2007 deal; that right had formerly been held by Dey LP, a wholly owned subsidiary of Merck. According to
3943:
3421:
3189:
4281:
3827:
3719:
3111:
2711:
2671:
2630:
2231:
1388:
508:
the FDA rescinded its approval based on its suspicions and filed criminal charges against Bolar, to which Bolar eventually pled guilty in 1991.
3785:
2798:
856:
In late July 2019, the company and Pfizer announced that Pfizer would spin off and merge its off-patent medicine division, Upjohn, with Mylan.
5178:
3920:
1227:
605:
May 2005. In June, the company bought back 25% of its shares in order to fend off Icahn. In July, Icahn gave up his bid and sold his shares.
2212:"Press release: FTC Reaches Record Financial Settlement To Settle Charges of Price-fixing in Generic Drug Market | Federal Trade Commission"
2034:
1892:
John Seaman and John T. Landry. Mylan 50 Years of Unconventional Success. Mylan, in association with University Press of New England, 2011.
1169:, chair of the Senate Judiciary Committee that launched the "probe of EpiPen pricing probe in 2016, released the analysis on May 30, 2017.
1139:
and the West Virginia State Attorney General opened an investigation into whether Mylan had given the state the correct discount under the
3334:
3284:
3006:
3699:
3493:
4132:
1087:'s competing product was recalled in November 2015 and further when Teva's generic competitor was rejected by the FDA in March 2016.
560:
transdermal patch and was the first company to market generic nitroglycerin, estradiol, clonidine, and fentanyl transdermal patches.
3649:
3387:
3665:
3466:
2776:
2457:
1830:
5213:
2190:
2278:
1445:
5233:
3170:
2304:
4157:
3875:
3132:
3598:
2837:
1413:
776:
17:
2983:
2487:
3067:
2078:
368:
102:
3764:
2576:"Mylan workers overrode drug quality controls Internal report detailed 'pervasive' practice of ignoring safety procedures"
300:
Mylan went public on the OTC market in February 1973. It was listed on the NASDAQ, and its shares were a component of the
5193:
3089:
464:
3309:
2656:
311:
The company was founded in 1961 and developed and produced medicines for a wide range of medical disciplines, including
2530:
2256:
1960:
1178:
1162:
544:; the deal was completed in 1988 but its consummation was dependent on FDA approval of selegiline, which came in 1989.
3686:
3578:
2754:
1487:
5218:
1897:
1698:
845:
614:
282:
192:
1918:
5137:
3515:
3047:
2596:
1688:
1501:
1151:
465 million announced by the company in October 2016. In October 2016, the company announced a settlement with the
1076:
2961:
5188:
2842:
2418:
1430:
1128:
563:
In 1996, the company acquired UDL Laboratories, a supplier of unit dose generic medications to institutional and
293:. Through these acquisitions, the company grew from the third-largest generic and pharmaceuticals company in the
3557:
3027:
1800:
1083:
had worked with on defibrillator legislation to do so. Mylan's efforts to gain market dominance were aided when
5005:
2171:
570:
In 1998 when it was the world's second largest generics company, the company came under investigation from the
922:
The following is an illustration of the company's major mergers and acquisitions and historical predecessors:
640:
Also in 2009, the company and its subsidiary UDL agreed to pay $ 118 million to settle a suit filed under the
4544:
4260:
2878:
1482:
4081:
2819:"Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business"
2349:
665:
for the exclusive worldwide rights to develop, manufacture and commercialize Pfizer's generic equivalent to
4763:
4307:
3174:
3156:
2553:
1575:
1140:
837:
645:
613:
In January 2007, the company acquired a controlling interest in Matrix Laboratories, an Indian supplier of
521:
396:
1640:
375:. The facility was moved to Pennsauken, New Jersey in 1962, to Princeton, West Virginia in 1963, and then
5120:
4574:
4351:
1425:
1161:
rebates. Simultaneously with the settlement, the company also announced it was being investigated by the
1049:
886:
transaction. Pfizer shareholders owned 57% of the combined new company and Mylan shareholders owned 43%.
2057:
4569:
4235:
903:
412:
3214:"Investor Presentations – August 2020 - Path to Shareholder Value Creation VIATRIS TSR Execution Plan"
3199:
4743:
4713:
4698:
4626:
4611:
4549:
4494:
2400:
1392:
376:
1760:
802:
between six pharmaceutical firms including informal gatherings, telephone calls, and text messages.
5075:
5010:
4718:
4459:
3666:"Another reason to hate Mylan, which jacked up the price of life-saving EpiPens: It's a tax dodger"
2634:
1152:
1061:
571:
271:
2939:
229:
5158:
4925:
4646:
4636:
4631:
4489:
4429:
3604:
3247:
2967:
2580:
2559:
2442:
2333:
2017:
2012:
1214:
911:
899:
633:
424:
267:
174:
4359:
3964:
3310:"Mylan's Merger with Pfizer's Off-Patent Drug Unit Will Create 'New Champion for Global Health'"
5030:
5000:
4950:
4905:
4753:
4444:
4339:
3342:
1055:
795:
320:
821:
manufactured by the company was voluntarily recalled due to the detection of trace amounts of
5105:
4910:
4728:
4693:
4539:
4519:
2755:"How Congress, the FDA, and Sarah Jessica Parker Helped EpiPen Become a $ 1 Billion Business"
1901:
1781:
1143:
and subpoenaed the company when it refused to provide the documentation the state requested.
822:
695:
70:
2631:"Four Pharmaceutical Companies Pay $ 124 Million for Submission of False Claims to Medicaid"
1801:"The Emerging Effects of the Drug Price Competition and Patent Term Restoration Act of 1984"
1690:
Mylan: 50 Years of Unconventional Success: Making Quality Medicine Affordable and Accessible
1156:(23%), and price hikes for generic drugs cannot be passed onto states, and a common form of
840:
announced its approval of the company's Wixela Inhub, the first approved generic version of
5065:
5040:
4990:
4985:
4965:
4915:
4848:
4838:
4708:
4683:
4591:
4586:
4554:
4484:
4454:
3687:
How Congress, the FDA, and Sarah Jessica Parker Helped EpiPen Become a $ 1 Billion Business
3365:"Mylan Upjohn Merger – Pfizer Shareholders to receive 0.12 Viatris Shares per Pfizer Share"
1157:
883:
851:
759:
596:
427:
under the ticker symbol MYL. Prior to the Viatris combination, the stock was traded on the
301:
1662:
1601:
467:
in 1980 and instead chose to market their products under their own "Mylan-labeled" brand.
8:
5090:
5055:
5045:
4970:
4955:
4678:
4673:
4414:
4404:
3748:
3264:"Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?"
2536:
1004:
859:
In November 2019, Mylan & Upjohn announced that the name of the new company would be
732:
579:
501:
423:. Their final stock move was in 1986, when their stock became available for trade on the
199:
3641:
644:
in which Mylan/UDL and two other companies were accused of underpaying states under the
5015:
4828:
4798:
4748:
4514:
4499:
4265:
4060:"Mylan Statement on its Policy Against the Use of Mylan Products in Capital Punishment"
4059:
4041:
3904:
3881:
3499:
3393:
3095:
2944:
2782:
2465:
2327:
2310:
2284:
2261:
2237:
2196:
2145:
2118:
2040:
1966:
1924:
1859:"Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984"
1835:
1766:
1450:
1222:
1191:
525:
328:
324:
4014:"Drug company is targeted for refusing to adopt ban on distribution of execution drug"
3364:
4995:
4960:
4449:
4033:
3849:"Silicon Valley engineers figure real cost to make lifesaving auto-injector two-pack"
3671:
3562:
2355:
2150:
2063:
1893:
1812:
1714:
1694:
1455:
1446:"Mylan Laboratories To Acquire Generics Business Of Merck KGaA For 4.9 Billion Euros"
553:
379:, West Virginia, in 1965, and in 1976 it relocated its corporate headquarters to the
4261:"Why the CEO Behind the EpiPen Controversy Is on Fortune's Most Powerful Women List"
4045:
407:
On February 23, 1973, Mylan had its initial public offering (IPO), when it became a
4723:
4661:
4641:
4596:
4581:
4524:
4025:
3769:
3621:"Mylan's EpiPen price increases are Valeant-like in size, Shkreli-like in approach"
3052:
3032:
2140:
2130:
1870:
1728:
1199:
641:
493:
352:
3720:"Mylan to provide EpiPen cost assistance as CEO is asked to testify on price hike"
297:
to the second-largest generic and specialty pharmaceuticals company in the world.
5070:
4980:
4975:
4616:
4564:
4534:
4013:
2515:
Cynthia Koons and Robert Langreth for Bloomberg Businessweek. September 23, 2015
2299:
1526:
1136:
841:
666:
408:
344:
247:
83:
4900:
4606:
4303:"Generic Drug Makers Face Pricing Issues Unlike Other Pharmaceutical Companies"
3012:
2989:
2862:
2458:"Press release: Mylan Completes Acquisition of Generics Business of Merck KGaA"
2360:
2135:
1875:
1858:
1232:
1166:
1113:
1066:
895:
564:
367:
Founded in 1961, the company was first located in an abandoned skating rink in
180:
5152:
5080:
4878:
4780:
4688:
2822:
1117:
728:
416:
372:
356:
294:
106:
3409:
Press Release: King Pharmaceuticals to Acquire Meridian Medical Technologies
4858:
4282:"As rebel Mylan investors win more backing, CEO Bresch champions her board"
4037:
3724:
3541:
3537:"Mylan chairman: Drug pricing critics ought to go copulate with themselves"
2799:"UPDATED: FDA castigates three Mylan sterile drug plants in warning letter"
2154:
1816:
1210:
799:
453:
445:
388:
243:
116:
4209:"SOMERSET ELDEPRYL JUNE 5 APPROVAL CLEARS WAY FOR MYLAN/BOLAR ACQUISITION"
3112:"Look out, Teva: Mylan's Copaxone copy has already captured serious share"
2097:"Somerset Eldepryl June 5 Approval Clears Way For Mylan/Bolar Acquisition"
731:, the company acquired the generic drugs business in developed markets of
5050:
4733:
4601:
3625:
2691:"Mylan joins the Advair-copycat queue, but approval could be a long slog"
1071:
707:
699:
574:
after it raised the prices of its products, tripling them in the case of
497:
392:
332:
316:
263:
2531:"How Mylan, the EpiPen company, maneuvered to create a virtual monopoly"
2401:"Mylan Signs US$ 736-mil. Takeover Deal for India's Matrix Laboratories"
852:
Merger with Pfizer's off-patent drug business and name change to Viatris
5110:
4738:
4469:
3744:"Why Mylan's 'savings card' won't make EpiPen cheaper for all patients"
3190:"Pfizer in talks to merge off-patent drugs business with Mylan: source"
976:
626:
601:
557:
541:
488:
In the 1980s one of the most prescribed drugs in the US was Dyazide, a
384:
380:
340:
336:
305:
290:
48:
4029:
3921:"For ripping off Medicaid, EpiPen maker Mylan pays Feds $ 465 million"
2712:"Mylan may have violated antitrust law in its EpiPen sales to schools"
5060:
4930:
4703:
4668:
4529:
4504:
3828:"Upgraded EpiPens torn apart. Tech firm: "It's the same core device""
2738:
1941:"U.s. Charges Bolar Pharmaceutical With Misrepresenting Its Products"
1857:
Boehm, Garth; Yao, Lixin; Han, Liang; Zheng, Qiang (September 2013).
1135:
program in New York to determine if the program's contracts violated
1080:
1060:
Mylan acquired the right to market and distribute the EpiPen line of
818:
575:
449:
348:
120:
3899:"Is EpiPen a Brand-Name or a Generic Drug? Mylan Casts It Both Ways"
3700:"No holds barred in Mylan's ultra-realistic peanut allergy campaign"
3422:"FDA swats down Teva's EpiPen copy, putting Mylan in cruise control"
4940:
4935:
4818:
4808:
4479:
3965:"Mylan may have overcharged U.S. for EpiPen by $ 1.27 billion: HHS"
3832:
2601:
2035:"F.D.A. Inquiry on Generic Drugs Focuses on Changes in Ingredients"
1550:
1237:
1121:
876:
764:
489:
444:
Mylan Pharmaceuticals was founded as a drug distributor in 1961 by
312:
2734:"Family matters: EpiPens had high-level help getting into schools"
5095:
4945:
4868:
4788:
4758:
4656:
4621:
4559:
4474:
4434:
4419:
4389:
4286:
3704:
3520:
3426:
3268:
3194:
3137:
3116:
3072:
2923:
2883:
2803:
2759:
2695:
1840:
1195:
1018:
872:
864:
860:
788:
779:; the product was PUR0200, a generic drug in a Pulmatrix device.
747:
286:
259:
163:
153:
3992:"EpiPen maker faces revolt over exec's $ 98 million pay package"
5100:
5035:
5025:
4920:
4651:
4464:
4409:
4334:
3809:"Mylan Investigations Mount as West Virginia Opens Fraud Probe"
3579:"People With Food Allergies Say Life-Saving Drug Too Expensive"
3450:
1206:
1084:
990:
907:
868:
670:
662:
625:
In October 2007, the company acquired the generics division of
520:, which investigated and found fraud and corruption within the
428:
420:
395:, a suburban business park located in the Pittsburgh suburb of
255:
251:
149:
3958:
3956:
3596:
Walker, Joseph; Winslow, Ron; Steele, Anne (August 30, 2016).
3385:
Parker-Pope, Tara; Peachman, Rachel Rabkin (August 22, 2016).
2940:"Why Mylan Just Lost The Largest Hostile Takeover Battle Ever"
2672:"GSK breathes freely as Mylan launches Seretide generic in UK"
2517:
How Marketing Turned the EpiPen Into a Billion-Dollar Business
2232:"Generic-Drug Maker Agrees to Settlement In Price-Fixing Case"
1075:
making EpiPens available in schools and in public places like
758:
Two weeks after the company made its first offer for Perrigo,
5115:
5085:
4509:
4439:
4424:
2419:"Mylan's Acquisition of Matrix: Business Strategy Case Study"
590:
278:
39:
3068:"Mylan snaps up dermatology biz from investors in $ 1B deal"
391:. Finally in 2004 it moved to a new office center in nearby
4895:
4082:"Milan Puskar, co-founder of Mylan, dies - Drug Store News"
3953:
3944:"Mylan Agrees to $ 465 Million EpiPen Settlement With U.S."
3876:"Mylan to Settle EpiPen Overpricing Case for $ 465 Million"
3446:"Why Did Mylan Hike EpiPen Prices 400%? Because They Could"
3335:"Pfizer to spinoff, merge off-patent drugs unit with Mylan"
2879:"Mylan buys female health businesses from Indian drugmaker"
2858:"US drugmaker Mylan to acquire Famy Care for $ 750 Million"
746:
In April 2015, the company attempted a hostile takeover of
456:
tablets as well as vitamins and other dietary supplements.
3786:"Mylan's EpiPen School Sales Trigger N.Y. Antitrust Probe"
3642:"5 Signs That EpiPen Prices Are Completely Out of Control"
3090:"20 States Accuse Generic Drug Companies of Price Fixing"
1218:
787:
In February 2016, the company announced it would acquire
710:, the father of Mylan's CEO, was a senator at that time.
218:
5204:
Companies formerly listed on the New York Stock Exchange
4326:
3388:"EpiPen Price Rise Sparks Concern for Allergy Sufferers"
277:
In 2007, the company acquired a controlling interest in
4236:"Merck KGaA sells generics unit to Mylan for $ 6.6 bln"
3467:"Cost Jumps Nearly 500-Percent For Life-Saving EpiPens"
2959:
Rockoff, Jonathan D.; Mattioli, Dana (April 22, 2015).
1165:
related to the drug rebate program. Republican Senator
285:(APIs) for generic drugs, and the generics business of
3243:"Viatris picked as new name for a merged Mylan/Upjohn"
3007:"Teva Snaps Up Allergan's Generics Arm, Dumping Mylan"
2919:"Mylan fails in $ 26 billion takeover bid for Perrigo"
2649:"Mylan acquires rights to Pfizer's inhaler technology"
2597:"It's Not Mylan's First Quality Control Beef With FDA"
2528:
Johnson, Carolyn Y.; Ho, Catherine (August 25, 2016).
2438:"Mylan buys Merck generic drug unit for $ 6.6 billion"
2112:
2110:
1502:"History of Mylan Laboratories Inc. – FundingUniverse"
281:-based Matrix Laboratories Limited, a top producer of
5164:
Defunct pharmaceutical companies of the United States
3784:
Larson, Erik; Hopkins, Jared S. (September 6, 2016).
2488:"Mylan completes acquisition of Merck's generic unit"
3807:
Feeley, Jef; Langreth, Robert (September 20, 2016).
3599:"Mylan to Launch Cheaper Generic EpiPen Alternative"
3516:"Drug Company Chairman to America: Go Fuck Yourself"
2574:
Sabatini, Patricia; Boselovic, Len (July 26, 2009).
1389:"After nearly 60 years, Mylan makes way for Viatris"
1094:
Starting in 2014, according to a 2017 report in the
1026:
Renaissance Acquisition Holdings (Dermatology div.)
661:
In 2011, the company entered into an agreement with
632:
In 2009, the company filed two lawsuits against the
3595:
3384:
2617:"Drug company Mylan, Post-Gazette resolve lawsuits"
2107:
1888:
1886:
1687:Seaman, John T.; Landry, John T. (April 10, 2012).
1478:"Pharmaceutical giants tracking Mylan's prosperity"
1418:
767:'s generic drug business for about the same price.
5224:Companies based in Washington County, Pennsylvania
3897:
3874:
3741:
3664:
3597:
3494:"Outcry Over EpiPen Prices Hasn't Made Them Lower"
3492:
3486:
3484:
3386:
3088:
3005:
2982:
2960:
2775:
2552:
2529:
2348:
2326:
2303:
2279:"Icahn Offers $ 5.4 Billion for Mylan, Drug Maker"
2277:
2230:
2189:
2119:"Recent trends in specialty pharma business model"
2056:
2033:
1959:
1917:
1759:
2727:
2725:
2709:
2573:
2511:
2509:
2507:
2505:
2503:
2501:
1831:"COMPANY NEWS; SmithKline Loses Drug Exclusivity"
691:National Association of State Boards of Education
552:The company acquired Bertek Inc. in 1993 for its
5150:
3868:
3866:
2710:Swetlitz, Ike; Silverman, Ed (August 26, 2016).
2079:"Bolar and Mylan Team to Purchase Somerset Labs"
2058:"FDA to Lift OK of Last Dyazide Generic Version"
1981:
1979:
1977:
1883:
1856:
1753:
1751:
1749:
1747:
1745:
1414:10-K for the Fiscal Year Ended December 31, 2015
741:
5174:Pharmaceutical companies disestablished in 2020
3983:
3481:
3028:"Mylan to Co-Develop Pulmatrix' COPD Candidate"
2958:
2191:"A Drug Maker Is Said to Face A Suit on Prices"
1805:Journal of Contemporary Health Law & Policy
1715:"Mylan 50 years young and still making history"
1551:"iShares Nasdaq Biotechnology Index Fund (IBB)"
681:In 2012, the company launched a program called
262:. Previously, the company was domiciled in the
3806:
3439:
3437:
3133:"Mylan and WVU announce 10 year collaboration"
2777:"Mylan Buys Drug Maker of Generic Injectables"
2722:
2498:
2250:
2248:
4391:Pharmaceutical companies of the United States
4375:
4158:"FDA approves generic forms of ciprofloxacin"
4007:
4005:
3863:
3783:
3285:"What The Pfizer-Mylan Deal Means For Pharma"
2731:
2305:"Icahn Slate Wins Seats on Blockbuster Board"
1974:
1742:
1626:
1624:
1622:
828:(NDEA) which is a probable human carcinogen.
753:
250:company. In November 2020, Mylan merged with
5169:Pharmaceutical companies established in 1961
4779:
3558:"Mylan Begins Harvesting the Crop It's Sown"
1686:
518:House Oversight and Investigations Committee
5229:Health care companies based in Pennsylvania
5199:Health care companies of the United Kingdom
3434:
3261:
2962:"Teva Offers to Buy Mylan for $ 40 Billion"
2917:Kareen Nair, Samantha (November 13, 2015).
2916:
2298:
2245:
2166:
2164:
1957:
1757:
894:On February 23, 1973, the company became a
656:
452:. In 1966, the company began manufacturing
4382:
4368:
4002:
3777:
3464:
3443:
3380:
3378:
3187:
3171:"FDA approves first generic Advair Diskus"
2984:"Teva to Buy Allergan's Generic Drug Unit"
2835:
2554:"Mylan Again Sues Pittsburgh Post-Gazette"
2183:
2181:
1915:
1619:
1131:began an investigation into the company's
831:
591:Attempted King Pharmaceuticals acquisition
228:
191:Generic and specialty pharmaceuticals and
4011:
3458:
2527:
2144:
2134:
2117:Ku, Mannching Sherry (December 1, 2015).
1874:
1633:"Milan Puskar, co-founder of Mylan, dies"
882:The deal was structured as an all-stock,
362:
258:'s off-patent medicine division, to form
3737:
3735:
3685:Matt Novak for Gizmodo. August 23, 2016
3576:
3570:
3241:Sabatini, Patricia (November 12, 2019).
3240:
3003:
2937:
2375:"US pharma major Mylan buys Matrix Labs"
2254:
2161:
1911:
1909:
1758:Freudenheim, Milt (September 10, 1989).
1630:
676:
483:
463:The company discontinued operating as a
5209:Companies formerly listed on the Nasdaq
5184:2020 disestablishments in West Virginia
4133:"Drugs@FDA: FDA Approved Drug Products"
4108:"Drugs@FDA: FDA Approved Drug Products"
3662:
3419:
3407:King Pharmaceuticals October 21, 2002.
3375:
3262:Blankenship, Kyle (November 12, 2019).
3109:
2900:"Mylan's Hostile Bid for Perrigo Fails"
2836:Tascarella, Patty (February 27, 2015).
2732:O'Donnell, Jayne (September 21, 2016).
2688:
2669:
2594:
2588:
2567:
2275:
2228:
2187:
2178:
2031:
1958:Freudenheim, Milt (February 28, 1991).
1852:
1850:
1177:In a report published on June 12, 2017
14:
5151:
4301:GATLIN, ALLISON (September 22, 2017).
4300:
4279:
3941:
3895:
3872:
3825:
3762:
3742:Carolyn Y. Johnson (August 25, 2016).
3639:
3490:
3282:
3130:
3086:
2876:
2796:
2773:
2435:
2054:
1916:Strickland, Carol (October 15, 1989).
1406:
1217:told the company that it was the only
917:
266:, with principal executive offices in
4363:
3962:
3732:
3697:
3618:
3577:Goldberg, Kenny (February 18, 2016).
3513:
3465:Bartolotta, Devin (August 18, 2016).
3444:Willingham, Emily (August 21, 2016).
2897:
2877:Nathan, Vidya L. (February 3, 2015).
2752:
2550:
2276:Pollack, Andrew (November 20, 2004).
2188:Labaton, Stephen (December 5, 1998).
1961:"Bolar Plans Guilty Plea On Generics"
1906:
1798:
1631:Dearment, Alaric (October 10, 2011).
1386:
1056:Heather Bresch § Mylan executive
1050:Epinephrine autoinjector § Price
777:chronic obstructive pulmonary disease
722:
620:
608:
535:
5179:1961 establishments in West Virginia
4233:
3918:
3663:Hiltzik, Michael (August 23, 2016).
3555:
3534:
2898:Koons, Cynthia (November 13, 2015).
2689:Helfand, Carly (February 22, 2016).
2172:"Mylan 1996 Form 10-K Annual Report"
2032:Andrews, Edmund L. (July 31, 1989).
2013:"US Judge to Rule on Drug Marketing"
2010:
1999:Approval History NDA 019129: Maxzide
1938:
1847:
1387:Gough, Paul J. (November 16, 2020).
1313:
1249:
1194:, which is approved by the state of
1079:are, and hired the same people that
991:Pfizer Respiratory Delivery Platform
906:market. In 1976, the stock moved to
713:
103:White Sulphur Springs, West Virginia
4348:Historical business data for Mylan:
3942:Tracer, Zachary (October 7, 2016).
3896:Thomas, Katie (September 2, 2016).
3763:Ramsey, Lydia (December 16, 2016).
3188:Ponnezhath, Maria (July 27, 2019).
3087:Thomas, Katie (December 15, 2016).
2938:WIECZNER, JEN (November 13, 2015).
2774:Thomas, Katie (February 27, 2013).
2551:Adams, Russell (October 30, 2009).
2055:Cimons, Marlene (August 29, 1989).
2011:Reid, Kenneth (November 17, 1987).
1919:"Bolar: A Drug Company Under Siege"
1005:Abbott Laboratories (Generics div.)
812:
782:
465:contract manufacturing organization
439:
27:Pharmaceutical company, now Viatris
24:
4669:Pharmaceutical Product Development
3826:Popken, Ben (September 30, 2016).
3765:"The $ 300 generic EpiPen is here"
3698:Bulik, Beth Snyder (May 1, 2016).
3652:from the original on May 25, 2022.
3110:Helfand, Carly (January 4, 2018).
3048:"Mylan to Acquire Meda for $ 9.9B"
3004:Somayaji, Chitra (July 27, 2015).
2255:Creswell, Julie (March 21, 2005).
2229:Labaton, Stephen (July 13, 2000).
2116:
1185:
1179:Institutional Shareholder Services
1163:Securities and Exchange Commission
25:
5245:
4318:
3873:Thomas, Katie (October 7, 2016).
3846:
2464:. October 2, 2007. Archived from
2123:Journal of Food and Drug Analysis
1939:Shaw, Donna (February 27, 1991).
1486:. August 13, 2008. Archived from
1043:
615:active pharmaceutical ingredients
419:MYLN. In 1976 the stock moved to
283:active pharmaceutical ingredients
193:active pharmaceutical ingredients
5138:List of pharmaceutical companies
4333:
4294:
4273:
4253:
4227:
4201:
4175:
4150:
4125:
4100:
4074:
4052:
3989:
3935:
3912:
3889:
3840:
3819:
3800:
3756:
3712:
3691:
3679:
3656:
3640:Tuttle, Brad (August 22, 2016).
3633:
3612:
3491:Duhigg, Charles (June 4, 2017).
3420:Helfand, Carly (March 1, 2016).
2838:"Mylan inversion deal completed"
2797:Palmer, Eric (August 18, 2015).
2324:
1172:
770:
38:
4280:Staton, Tracy (June 15, 2017).
3963:Erman, Michael (May 31, 2017).
3619:Court, Emma (August 18, 2016).
3589:
3549:
3528:
3507:
3413:
3401:
3357:
3341:. July 29, 2019. Archived from
3327:
3302:
3283:Brozak, Steve (July 29, 2019).
3276:
3255:
3234:
3206:
3181:
3163:
3145:
3124:
3103:
3080:
3060:
3040:
3020:
2997:
2975:
2952:
2931:
2910:
2891:
2870:
2850:
2843:American City Business Journals
2829:
2811:
2790:
2767:
2753:Novak, Matt (August 23, 2016).
2746:
2703:
2682:
2663:
2641:
2623:
2609:
2544:
2521:
2480:
2450:
2429:
2411:
2393:
2367:
2341:
2318:
2292:
2269:
2222:
2204:
2089:
2071:
2048:
2025:
2004:
2001:Page accessed September 8, 2016
1991:
1951:
1932:
1823:
1792:
1774:
1721:
1707:
1680:
1655:
1594:
1431:American City Business Journals
1426:"Mylan buys part of drug maker"
1129:New York State Attorney General
206:
5214:1970s initial public offerings
4012:Owen Dyer (October 24, 2014).
3919:Mole, Beth (October 7, 2016).
3131:Hudock, Megan (May 14, 2018).
2595:Edwards, Jim (July 28, 2009).
2436:Massey, Steve (May 13, 2007).
1568:
1543:
1519:
1494:
1470:
1454:. May 26, 2007. Archived from
1438:
1380:
270:, UK and a "Global Center" in
13:
1:
5234:2020 mergers and acquisitions
4545:Institute for OneWorld Health
3556:Loew, Derek (June 12, 2017).
2670:Stanton, Dan (June 8, 2015).
1663:"A Tale of Two Entrepreneurs"
1483:The Pittsburgh Tribune-Review
1374:
1366:
914:, then later back to NASDAQ.
910:and in 1986, it moved to the
742:Attempted Perrigo acquisition
4764:West Pharmaceutical Services
3514:Novak, Matt (June 5, 2017).
3175:Food and Drug Administration
3157:Food and Drug Administration
1985:Pink Sheet October 22, 1984
1141:Medicaid Drug Rebate Program
1038:
735:for $ 5.3 billion in stock.
646:Medicaid Drug Rebate Program
522:Food and Drug Administration
7:
3535:Mole, Beth (June 5, 2017).
2350:"Icahn Drops Bid for Mylan"
1863:Acta Pharmaceutica Sinica B
1729:"MYL Stock History - Mylan"
1244:
1182:of the existing directors.
10:
5250:
5194:Generic drug manufacturers
4570:McNeil Consumer Healthcare
3221:Champion For Global Health
2136:10.1016/j.jfda.2015.04.008
1876:10.1016/j.apsb.2013.07.004
1221:-approved manufacturer of
1053:
1047:
977:Merck KGaA (Generics div.)
889:
754:Attempted purchase by Teva
434:
359:, and women's healthcare.
5133:
5076:Smith, Kline & French
4888:
4772:
4627:Northwest Biotherapeutics
4612:Merrimack Pharmaceuticals
4397:
4308:Investor's Business Daily
1393:Pittsburgh Business Times
1198:for use in executions by
1190:The company manufactures
984:Bioniche Pharma Holdings
940:Somerset Pharmaceuticals
595:In 2004, the company and
213:
198:
187:
169:
159:
144:
126:
112:
89:
79:
66:
58:
46:
37:
5219:Canonsburg, Pennsylvania
2635:US Department of Justice
1799:Lewis, Ralph A. (1992).
1602:"Therapeutic Innovation"
1153:US Department of Justice
1062:epinephrine autoinjector
657:Generic Advair agreement
651:
585:
572:Federal Trade Commission
547:
475:With the passage of the
470:
402:
272:Canonsburg, Pennsylvania
3605:The Wall Street Journal
3248:Pittsburgh Post-Gazette
2968:The Wall Street Journal
2581:Pittsburgh Post-Gazette
2560:The Wall Street Journal
2443:Pittsburgh Post-Gazette
2018:The Journal of Commerce
1786:www.thepharmaletter.com
1506:www.fundinguniverse.com
1205:In September 2014, the
1127:In September 2016, the
912:New York Stock Exchange
900:initial public offering
832:Generic Advair approval
800:price collusion schemes
796:State attorneys general
727:In February 2015, in a
634:Pittsburgh Post-Gazette
425:New York Stock Exchange
268:Hatfield, Hertfordshire
175:Hatfield, Hertfordshire
5189:Life sciences industry
5001:Leiner Health Products
4445:Amneal Pharmaceuticals
4137:www.accessdata.fda.gov
4112:www.accessdata.fda.gov
2676:in-Pharma Technologist
794:In December 2016, the
689:In December 2012, the
363:Corporate headquarters
130:November 16, 2020
4555:Johnson & Johnson
2494:. September 30, 2008.
1945:Philadelphia Inquirer
1761:"Exposing the F.D.A."
1490:on September 8, 2008.
1301:Cipro (Ciprofloxacin)
836:In January 2019, the
677:EpiPen4Schools launch
484:Dyazide & Maxzide
369:White Sulphur Springs
132:; 3 years ago
18:Mylan Pharmaceuticals
4849:Jazz Pharmaceuticals
4839:Horizon Therapeutics
4709:Sarepta Therapeutics
4684:Proteon Therapeutics
4679:Procter & Gamble
4592:Melinta Therapeutics
4485:Bristol Myers Squibb
4342:at Wikimedia Commons
3371:. November 17, 2020.
3056:. February 11, 2016.
2825:. February 27, 2015.
2218:. November 29, 2000.
2085:. November 14, 1988.
1782:"Mylan Laboratories"
1458:on February 24, 2008
1434:. December 18, 2006.
1268:Penicillin G tablets
1158:pharmaceutical fraud
970:Matrix Laboratories
884:Reverse Morris Trust
826:-nitrosodiethylamine
760:Teva Pharmaceuticals
597:King Pharmaceuticals
302:NASDAQ Biotechnology
5056:Repros Therapeutics
4971:Forest Laboratories
4956:Cutter Laboratories
4674:Prasco Laboratories
4415:Acorda Therapeutics
4405:Abbott Laboratories
3749:The Washington Post
3177:. January 30, 2019.
3159:. December 4, 2018.
2866:. February 3, 2015.
2637:. October 19, 2009.
2537:The Chicago Tribune
2328:"Survival Strategy"
2257:"Icahn the Spoiler"
1667:www.wvexecutive.com
918:Acquisition history
733:Abbott Laboratories
580:Cambrex Corporation
502:hydrochlorothiazide
34:
5016:Miles Laboratories
5006:Martek Biosciences
4829:Endo International
4749:Ventria Bioscience
4515:Danco Laboratories
4234:Kusjanto, Mantik.
4189:. October 22, 1984
4088:. October 10, 2011
3905:The New York Times
3882:The New York Times
3851:. The Mercury News
3728:. August 25, 2016.
3500:The New York Times
3394:The New York Times
3096:The New York Times
2783:The New York Times
2407:. August 28, 2006.
2379:The Economic Times
2311:The New York Times
2285:The New York Times
2238:The New York Times
2197:The New York Times
2041:The New York Times
1967:The New York Times
1925:The New York Times
1843:. August 22, 1987.
1836:The New York Times
1767:The New York Times
1451:Medical News Today
1223:rocuronium bromide
1192:rocuronium bromide
998:Agila Specialties
926:Mylan Acquisitions
723:Abbott acquisition
621:EpiPen acquisition
609:Matrix acquisition
536:Acquisitions begin
526:Par Pharmaceutical
349:infectious disease
32:
5146:
5145:
5129:
5128:
4961:DNAPrint Genomics
4450:Avax Technologies
4338:Media related to
4030:10.1136/bmj.g6452
3672:Los Angeles Times
3583:KPBS Public Media
3202:on July 27, 2019.
3173:(Press release).
3155:(Press release).
2821:(Press release).
2653:drugstorenews.com
2633:(Press release).
2381:. August 29, 2006
2356:Los Angeles Times
2325:Lazo, Shirley A.
2064:Los Angeles Times
1582:. October 5, 2017
1580:marketrealist.com
1364:
1363:
1314:Branded Medicines
1311:
1310:
1250:Generic Medicines
1029:
1023:
1015:
1009:
1001:
995:
987:
981:
973:
967:
961:
958:UDL Laboratories
955:
949:
943:
937:
714:Agila acquisition
554:transdermal patch
415:market under the
237:
236:
74:(under Dutch law)
16:(Redirected from
5241:
4777:
4776:
4724:Tec Laboratories
4597:Melior Discovery
4582:Kinetic Concepts
4525:Galena Biopharma
4384:
4377:
4370:
4361:
4360:
4337:
4330:
4329:
4327:Official website
4313:
4312:
4298:
4292:
4291:
4277:
4271:
4270:
4257:
4251:
4250:
4248:
4246:
4231:
4225:
4224:
4222:
4220:
4205:
4199:
4198:
4196:
4194:
4179:
4173:
4172:
4170:
4168:
4154:
4148:
4147:
4145:
4143:
4129:
4123:
4122:
4120:
4118:
4104:
4098:
4097:
4095:
4093:
4078:
4072:
4071:
4069:
4067:
4056:
4050:
4049:
4009:
4000:
3999:
3987:
3981:
3980:
3978:
3976:
3960:
3951:
3950:
3939:
3933:
3932:
3930:
3928:
3916:
3910:
3909:
3901:
3893:
3887:
3886:
3878:
3870:
3861:
3860:
3858:
3856:
3844:
3838:
3837:
3823:
3817:
3816:
3804:
3798:
3797:
3795:
3793:
3781:
3775:
3774:
3770:Business Insider
3760:
3754:
3753:
3739:
3730:
3729:
3716:
3710:
3709:
3695:
3689:
3683:
3677:
3676:
3668:
3660:
3654:
3653:
3637:
3631:
3630:
3616:
3610:
3609:
3601:
3593:
3587:
3586:
3574:
3568:
3567:
3553:
3547:
3546:
3532:
3526:
3525:
3511:
3505:
3504:
3496:
3488:
3479:
3478:
3476:
3474:
3462:
3456:
3455:
3441:
3432:
3431:
3417:
3411:
3405:
3399:
3398:
3390:
3382:
3373:
3372:
3361:
3355:
3354:
3352:
3350:
3345:on July 29, 2019
3331:
3325:
3324:
3322:
3320:
3306:
3300:
3299:
3297:
3295:
3280:
3274:
3273:
3259:
3253:
3252:
3238:
3232:
3231:
3229:
3227:
3218:
3210:
3204:
3203:
3198:. Archived from
3185:
3179:
3178:
3167:
3161:
3160:
3149:
3143:
3142:
3128:
3122:
3121:
3107:
3101:
3100:
3092:
3084:
3078:
3077:
3064:
3058:
3057:
3053:Mary Ann Liebert
3044:
3038:
3037:
3036:. June 16, 2015.
3033:Mary Ann Liebert
3024:
3018:
3017:
3009:
3001:
2995:
2994:
2993:. July 27, 2015.
2986:
2979:
2973:
2972:
2964:
2956:
2950:
2949:
2935:
2929:
2928:
2914:
2908:
2907:
2895:
2889:
2888:
2874:
2868:
2867:
2854:
2848:
2847:
2833:
2827:
2826:
2815:
2809:
2808:
2794:
2788:
2787:
2779:
2771:
2765:
2764:
2750:
2744:
2743:
2729:
2720:
2719:
2707:
2701:
2700:
2686:
2680:
2679:
2667:
2661:
2660:
2655:. Archived from
2645:
2639:
2638:
2627:
2621:
2620:
2613:
2607:
2606:
2592:
2586:
2585:
2571:
2565:
2564:
2556:
2548:
2542:
2541:
2533:
2525:
2519:
2513:
2496:
2495:
2484:
2478:
2477:
2475:
2473:
2468:on June 19, 2018
2454:
2448:
2447:
2433:
2427:
2426:
2415:
2409:
2408:
2397:
2391:
2390:
2388:
2386:
2371:
2365:
2364:
2363:. July 29, 2005.
2352:
2345:
2339:
2338:
2330:
2322:
2316:
2315:
2307:
2302:(May 12, 2005).
2296:
2290:
2289:
2281:
2273:
2267:
2266:
2252:
2243:
2242:
2234:
2226:
2220:
2219:
2208:
2202:
2201:
2193:
2185:
2176:
2175:
2168:
2159:
2158:
2148:
2138:
2114:
2105:
2104:
2103:. June 12, 1989.
2093:
2087:
2086:
2075:
2069:
2068:
2060:
2052:
2046:
2045:
2037:
2029:
2023:
2022:
2008:
2002:
1995:
1989:
1983:
1972:
1971:
1963:
1955:
1949:
1948:
1936:
1930:
1929:
1921:
1913:
1904:
1890:
1881:
1880:
1878:
1854:
1845:
1844:
1827:
1821:
1820:
1796:
1790:
1789:
1778:
1772:
1771:
1763:
1755:
1740:
1739:
1737:
1735:
1725:
1719:
1718:
1711:
1705:
1704:
1684:
1678:
1677:
1675:
1673:
1659:
1653:
1652:
1650:
1648:
1639:. Archived from
1628:
1617:
1616:
1614:
1612:
1598:
1592:
1591:
1589:
1587:
1576:"Market Realist"
1572:
1566:
1565:
1563:
1561:
1547:
1541:
1540:
1538:
1536:
1523:
1517:
1516:
1514:
1512:
1498:
1492:
1491:
1474:
1468:
1467:
1465:
1463:
1442:
1436:
1435:
1422:
1416:
1410:
1404:
1403:
1401:
1399:
1384:
1327:Year Introduced
1318:
1317:
1263:Year Introduced
1254:
1253:
1236:
1200:lethal injection
1147:for a two-pack.
1027:
1021:
1013:
1007:
999:
993:
985:
979:
971:
965:
959:
953:
947:
941:
935:
813:Valsartan recall
783:Meda acquisition
642:False Claims Act
494:combination drug
477:Hatch-Waxman Act
440:Founding to 1980
353:gastroenterology
233:
232:
225:
222:
220:
140:
138:
133:
100:
98:
75:
42:
35:
31:
21:
5249:
5248:
5244:
5243:
5242:
5240:
5239:
5238:
5149:
5148:
5147:
5142:
5125:
5071:Schering-Plough
4981:ImClone Systems
4884:
4768:
4617:Myriad Genetics
4607:Merck & Co.
4565:Janssen Biotech
4535:Gilead Sciences
4393:
4388:
4356:
4325:
4324:
4321:
4316:
4299:
4295:
4278:
4274:
4259:
4258:
4254:
4244:
4242:
4232:
4228:
4218:
4216:
4215:. June 12, 1989
4207:
4206:
4202:
4192:
4190:
4181:
4180:
4176:
4166:
4164:
4156:
4155:
4151:
4141:
4139:
4131:
4130:
4126:
4116:
4114:
4106:
4105:
4101:
4091:
4089:
4086:Drug Store News
4080:
4079:
4075:
4065:
4063:
4058:
4057:
4053:
4010:
4003:
3988:
3984:
3974:
3972:
3961:
3954:
3940:
3936:
3926:
3924:
3917:
3913:
3894:
3890:
3871:
3864:
3854:
3852:
3847:Tracy, Seipel.
3845:
3841:
3824:
3820:
3805:
3801:
3791:
3789:
3782:
3778:
3761:
3757:
3740:
3733:
3718:
3717:
3713:
3696:
3692:
3684:
3680:
3661:
3657:
3638:
3634:
3617:
3613:
3594:
3590:
3575:
3571:
3554:
3550:
3533:
3529:
3512:
3508:
3489:
3482:
3472:
3470:
3469:. CBS Baltimore
3463:
3459:
3442:
3435:
3418:
3414:
3406:
3402:
3383:
3376:
3363:
3362:
3358:
3348:
3346:
3333:
3332:
3328:
3318:
3316:
3308:
3307:
3303:
3293:
3291:
3281:
3277:
3260:
3256:
3239:
3235:
3225:
3223:
3216:
3212:
3211:
3207:
3186:
3182:
3169:
3168:
3164:
3151:
3150:
3146:
3129:
3125:
3108:
3104:
3085:
3081:
3076:. May 13, 2016.
3066:
3065:
3061:
3046:
3045:
3041:
3026:
3025:
3021:
3002:
2998:
2981:
2980:
2976:
2957:
2953:
2936:
2932:
2915:
2911:
2896:
2892:
2875:
2871:
2856:
2855:
2851:
2834:
2830:
2817:
2816:
2812:
2795:
2791:
2772:
2768:
2751:
2747:
2730:
2723:
2708:
2704:
2687:
2683:
2668:
2664:
2659:on May 9, 2015.
2647:
2646:
2642:
2629:
2628:
2624:
2615:
2614:
2610:
2593:
2589:
2572:
2568:
2549:
2545:
2526:
2522:
2514:
2499:
2486:
2485:
2481:
2471:
2469:
2456:
2455:
2451:
2434:
2430:
2417:
2416:
2412:
2399:
2398:
2394:
2384:
2382:
2373:
2372:
2368:
2347:
2346:
2342:
2323:
2319:
2297:
2293:
2274:
2270:
2253:
2246:
2227:
2223:
2210:
2209:
2205:
2186:
2179:
2170:
2169:
2162:
2115:
2108:
2095:
2094:
2090:
2077:
2076:
2072:
2053:
2049:
2030:
2026:
2009:
2005:
1996:
1992:
1984:
1975:
1956:
1952:
1937:
1933:
1914:
1907:
1891:
1884:
1855:
1848:
1829:
1828:
1824:
1797:
1793:
1780:
1779:
1775:
1756:
1743:
1733:
1731:
1727:
1726:
1722:
1713:
1712:
1708:
1701:
1685:
1681:
1671:
1669:
1661:
1660:
1656:
1646:
1644:
1637:Drug Store News
1629:
1620:
1610:
1608:
1600:
1599:
1595:
1585:
1583:
1574:
1573:
1569:
1559:
1557:
1549:
1548:
1544:
1534:
1532:
1525:
1524:
1520:
1510:
1508:
1500:
1499:
1495:
1476:
1475:
1471:
1461:
1459:
1444:
1443:
1439:
1424:
1423:
1419:
1411:
1407:
1397:
1395:
1385:
1381:
1377:
1369:
1316:
1252:
1247:
1230:
1188:
1186:Execution drugs
1175:
1058:
1052:
1046:
1041:
1036:
1035:
1034:
927:
920:
892:
854:
842:GlaxoSmithKline
834:
815:
785:
773:
756:
744:
725:
716:
679:
667:GlaxoSmithKline
659:
654:
623:
611:
593:
588:
550:
538:
486:
473:
442:
437:
411:company on the
409:publicly traded
405:
365:
345:pain management
321:antiretrovirals
248:pharmaceuticals
227:
217:
183:
177:
136:
134:
131:
119:
96:
94:
84:Pharmaceuticals
73:
51:
28:
23:
22:
15:
12:
11:
5:
5247:
5237:
5236:
5231:
5226:
5221:
5216:
5211:
5206:
5201:
5196:
5191:
5186:
5181:
5176:
5171:
5166:
5161:
5159:Tax inversions
5144:
5143:
5141:
5140:
5134:
5131:
5130:
5127:
5126:
5124:
5123:
5118:
5113:
5108:
5103:
5098:
5093:
5088:
5083:
5078:
5073:
5068:
5063:
5058:
5053:
5048:
5043:
5038:
5033:
5028:
5023:
5018:
5013:
5008:
5003:
4998:
4993:
4988:
4983:
4978:
4973:
4968:
4963:
4958:
4953:
4948:
4943:
4938:
4933:
4928:
4923:
4918:
4913:
4908:
4903:
4901:Allergan, Inc.
4898:
4892:
4890:
4886:
4885:
4883:
4882:
4881:(Canada, 2010)
4876:
4866:
4856:
4846:
4836:
4826:
4816:
4806:
4796:
4785:
4783:
4774:
4770:
4769:
4767:
4766:
4761:
4756:
4751:
4746:
4741:
4736:
4731:
4726:
4721:
4716:
4711:
4706:
4701:
4696:
4691:
4686:
4681:
4676:
4671:
4666:
4665:
4664:
4659:
4649:
4644:
4639:
4634:
4632:Norwich Pharma
4629:
4624:
4619:
4614:
4609:
4604:
4599:
4594:
4589:
4584:
4579:
4578:
4577:
4572:
4567:
4562:
4552:
4547:
4542:
4537:
4532:
4527:
4522:
4517:
4512:
4507:
4502:
4497:
4492:
4487:
4482:
4477:
4472:
4467:
4462:
4457:
4452:
4447:
4442:
4437:
4432:
4427:
4422:
4417:
4412:
4407:
4401:
4399:
4395:
4394:
4387:
4386:
4379:
4372:
4364:
4358:
4357:
4355:
4354:
4349:
4345:
4343:
4331:
4320:
4319:External links
4317:
4315:
4314:
4293:
4272:
4252:
4226:
4200:
4174:
4149:
4124:
4099:
4073:
4051:
4024:(349): g6452.
4001:
3982:
3952:
3934:
3923:. Ars Technica
3911:
3888:
3862:
3839:
3818:
3813:Bloomberg News
3799:
3776:
3755:
3731:
3711:
3690:
3678:
3655:
3632:
3611:
3588:
3569:
3548:
3527:
3506:
3480:
3457:
3433:
3412:
3400:
3374:
3369:Mr. Virk Media
3356:
3326:
3301:
3275:
3254:
3233:
3205:
3180:
3162:
3144:
3123:
3102:
3079:
3059:
3039:
3019:
3013:Bloomberg News
2996:
2990:Bloomberg News
2974:
2951:
2930:
2909:
2890:
2869:
2863:Times Internet
2849:
2828:
2810:
2789:
2766:
2745:
2721:
2702:
2681:
2662:
2640:
2622:
2608:
2587:
2566:
2543:
2520:
2497:
2479:
2449:
2428:
2410:
2392:
2366:
2361:Bloomberg News
2340:
2317:
2291:
2268:
2244:
2221:
2203:
2177:
2160:
2129:(4): 595–608.
2106:
2088:
2070:
2047:
2024:
2003:
1990:
1973:
1950:
1931:
1905:
1882:
1869:(5): 297–311.
1846:
1822:
1811:(1): 361–378.
1791:
1773:
1741:
1720:
1706:
1699:
1679:
1654:
1643:on May 3, 2017
1618:
1593:
1567:
1542:
1518:
1493:
1469:
1437:
1417:
1405:
1378:
1376:
1373:
1368:
1365:
1362:
1361:
1358:
1355:
1351:
1350:
1347:
1344:
1340:
1339:
1336:
1335:Blood pressure
1333:
1329:
1328:
1325:
1322:
1315:
1312:
1309:
1308:
1305:
1302:
1298:
1297:
1294:
1291:
1287:
1286:
1283:
1280:
1276:
1275:
1272:
1269:
1265:
1264:
1261:
1258:
1251:
1248:
1246:
1243:
1187:
1184:
1174:
1171:
1167:Chuck Grassley
1133:EpiPen4Schools
1114:Martin Shkreli
1096:New York Times
1077:defibrillators
1067:Bloomberg News
1045:
1044:EpiPen pricing
1042:
1040:
1037:
1033:
1032:
1031:
1030:
1024:
1016:
1010:
1002:
996:
988:
982:
974:
968:
962:
956:
950:
946:Dow B. Hickam
944:
936:(Founded 1961)
929:
928:
925:
924:
919:
916:
902:(IPO), on the
896:public company
891:
888:
853:
850:
833:
830:
814:
811:
784:
781:
772:
769:
755:
752:
743:
740:
724:
721:
715:
712:
683:EpiPen4Schools
678:
675:
658:
655:
653:
650:
622:
619:
610:
607:
592:
589:
587:
584:
565:long-term care
549:
546:
537:
534:
485:
482:
472:
469:
441:
438:
436:
433:
404:
401:
397:Cecil Township
364:
361:
355:, diabetology/
325:cardiovascular
246:and specialty
235:
234:
215:
211:
210:
202:
196:
195:
189:
185:
184:
181:United Kingdom
179:
173:
171:
167:
166:
161:
157:
156:
146:
142:
141:
128:
124:
123:
114:
110:
109:
91:
87:
86:
81:
77:
76:
68:
64:
63:
60:
56:
55:
52:
47:
44:
43:
26:
9:
6:
4:
3:
2:
5246:
5235:
5232:
5230:
5227:
5225:
5222:
5220:
5217:
5215:
5212:
5210:
5207:
5205:
5202:
5200:
5197:
5195:
5192:
5190:
5187:
5185:
5182:
5180:
5177:
5175:
5172:
5170:
5167:
5165:
5162:
5160:
5157:
5156:
5154:
5139:
5136:
5135:
5132:
5122:
5119:
5117:
5114:
5112:
5109:
5107:
5104:
5102:
5099:
5097:
5094:
5092:
5089:
5087:
5084:
5082:
5081:Sterling Drug
5079:
5077:
5074:
5072:
5069:
5067:
5064:
5062:
5059:
5057:
5054:
5052:
5049:
5047:
5044:
5042:
5039:
5037:
5034:
5032:
5029:
5027:
5024:
5022:
5019:
5017:
5014:
5012:
5009:
5007:
5004:
5002:
4999:
4997:
4994:
4992:
4989:
4987:
4984:
4982:
4979:
4977:
4974:
4972:
4969:
4967:
4964:
4962:
4959:
4957:
4954:
4952:
4949:
4947:
4944:
4942:
4939:
4937:
4934:
4932:
4929:
4927:
4924:
4922:
4919:
4917:
4914:
4912:
4909:
4907:
4904:
4902:
4899:
4897:
4894:
4893:
4891:
4887:
4880:
4879:Bausch Health
4877:
4874:
4870:
4867:
4864:
4860:
4857:
4854:
4850:
4847:
4844:
4840:
4837:
4834:
4830:
4827:
4824:
4820:
4817:
4814:
4810:
4807:
4804:
4800:
4797:
4794:
4790:
4787:
4786:
4784:
4782:
4781:Tax inversion
4778:
4775:
4771:
4765:
4762:
4760:
4757:
4755:
4752:
4750:
4747:
4745:
4742:
4740:
4737:
4735:
4732:
4730:
4727:
4725:
4722:
4720:
4717:
4715:
4712:
4710:
4707:
4705:
4702:
4700:
4697:
4695:
4692:
4690:
4689:Purdue Pharma
4687:
4685:
4682:
4680:
4677:
4675:
4672:
4670:
4667:
4663:
4660:
4658:
4655:
4654:
4653:
4650:
4648:
4645:
4643:
4640:
4638:
4635:
4633:
4630:
4628:
4625:
4623:
4620:
4618:
4615:
4613:
4610:
4608:
4605:
4603:
4600:
4598:
4595:
4593:
4590:
4588:
4585:
4583:
4580:
4576:
4573:
4571:
4568:
4566:
4563:
4561:
4558:
4557:
4556:
4553:
4551:
4548:
4546:
4543:
4541:
4538:
4536:
4533:
4531:
4528:
4526:
4523:
4521:
4518:
4516:
4513:
4511:
4508:
4506:
4503:
4501:
4498:
4496:
4493:
4491:
4488:
4486:
4483:
4481:
4478:
4476:
4473:
4471:
4468:
4466:
4463:
4461:
4458:
4456:
4453:
4451:
4448:
4446:
4443:
4441:
4438:
4436:
4433:
4431:
4428:
4426:
4423:
4421:
4418:
4416:
4413:
4411:
4408:
4406:
4403:
4402:
4400:
4396:
4392:
4385:
4380:
4378:
4373:
4371:
4366:
4365:
4362:
4353:
4350:
4347:
4346:
4344:
4341:
4336:
4332:
4328:
4323:
4322:
4310:
4309:
4304:
4297:
4289:
4288:
4283:
4276:
4268:
4267:
4262:
4256:
4241:
4237:
4230:
4214:
4210:
4204:
4188:
4184:
4178:
4163:
4159:
4153:
4138:
4134:
4128:
4113:
4109:
4103:
4087:
4083:
4077:
4061:
4055:
4047:
4043:
4039:
4035:
4031:
4027:
4023:
4019:
4015:
4008:
4006:
3997:
3993:
3986:
3970:
3966:
3959:
3957:
3948:
3947:Bloomberg.com
3945:
3938:
3922:
3915:
3907:
3906:
3900:
3892:
3884:
3883:
3877:
3869:
3867:
3850:
3843:
3835:
3834:
3829:
3822:
3814:
3810:
3803:
3787:
3780:
3772:
3771:
3766:
3759:
3751:
3750:
3745:
3738:
3736:
3727:
3726:
3721:
3715:
3707:
3706:
3701:
3694:
3688:
3682:
3674:
3673:
3667:
3659:
3651:
3647:
3643:
3636:
3628:
3627:
3622:
3615:
3607:
3606:
3600:
3592:
3584:
3580:
3573:
3565:
3564:
3559:
3552:
3544:
3543:
3538:
3531:
3523:
3522:
3517:
3510:
3502:
3501:
3495:
3487:
3485:
3468:
3461:
3453:
3452:
3447:
3440:
3438:
3429:
3428:
3423:
3416:
3410:
3404:
3396:
3395:
3389:
3381:
3379:
3370:
3366:
3360:
3344:
3340:
3336:
3330:
3315:
3311:
3305:
3290:
3286:
3279:
3271:
3270:
3265:
3258:
3250:
3249:
3244:
3237:
3222:
3215:
3209:
3201:
3197:
3196:
3191:
3184:
3176:
3172:
3166:
3158:
3154:
3148:
3140:
3139:
3134:
3127:
3119:
3118:
3113:
3106:
3098:
3097:
3091:
3083:
3075:
3074:
3069:
3063:
3055:
3054:
3049:
3043:
3035:
3034:
3029:
3023:
3015:
3014:
3008:
3000:
2992:
2991:
2985:
2978:
2970:
2969:
2963:
2955:
2947:
2946:
2941:
2934:
2926:
2925:
2920:
2913:
2905:
2901:
2894:
2886:
2885:
2880:
2873:
2865:
2864:
2859:
2853:
2845:
2844:
2839:
2832:
2824:
2823:Business Wire
2820:
2814:
2806:
2805:
2800:
2793:
2785:
2784:
2778:
2770:
2762:
2761:
2756:
2749:
2741:
2740:
2735:
2728:
2726:
2717:
2713:
2706:
2698:
2697:
2692:
2685:
2677:
2673:
2666:
2658:
2654:
2650:
2644:
2636:
2632:
2626:
2618:
2612:
2604:
2603:
2598:
2591:
2583:
2582:
2577:
2570:
2562:
2561:
2555:
2547:
2539:
2538:
2532:
2524:
2518:
2512:
2510:
2508:
2506:
2504:
2502:
2493:
2489:
2483:
2467:
2463:
2459:
2453:
2445:
2444:
2439:
2432:
2424:
2420:
2414:
2406:
2402:
2396:
2380:
2376:
2370:
2362:
2358:
2357:
2351:
2344:
2336:
2335:
2329:
2321:
2313:
2312:
2306:
2301:
2300:O'keefe, Eric
2295:
2287:
2286:
2280:
2272:
2264:
2263:
2258:
2251:
2249:
2240:
2239:
2233:
2225:
2217:
2213:
2207:
2199:
2198:
2192:
2184:
2182:
2173:
2167:
2165:
2156:
2152:
2147:
2142:
2137:
2132:
2128:
2124:
2120:
2113:
2111:
2102:
2098:
2092:
2084:
2080:
2074:
2066:
2065:
2059:
2051:
2043:
2042:
2036:
2028:
2020:
2019:
2014:
2007:
2000:
1994:
1988:
1982:
1980:
1978:
1969:
1968:
1962:
1954:
1946:
1942:
1935:
1927:
1926:
1920:
1912:
1910:
1903:
1899:
1898:9781611682700
1895:
1889:
1887:
1877:
1872:
1868:
1864:
1860:
1853:
1851:
1842:
1838:
1837:
1832:
1826:
1818:
1814:
1810:
1806:
1802:
1795:
1787:
1783:
1777:
1769:
1768:
1762:
1754:
1752:
1750:
1748:
1746:
1730:
1724:
1716:
1710:
1702:
1700:9781611682700
1696:
1692:
1691:
1683:
1668:
1664:
1658:
1642:
1638:
1634:
1627:
1625:
1623:
1607:
1606:www.mylan.com
1603:
1597:
1581:
1577:
1571:
1556:
1552:
1546:
1531:
1528:
1522:
1507:
1503:
1497:
1489:
1485:
1484:
1479:
1473:
1457:
1453:
1452:
1447:
1441:
1433:
1432:
1427:
1421:
1415:
1409:
1394:
1390:
1383:
1379:
1372:
1359:
1356:
1353:
1352:
1348:
1345:
1342:
1341:
1337:
1334:
1331:
1330:
1326:
1323:
1320:
1319:
1306:
1303:
1300:
1299:
1295:
1292:
1289:
1288:
1284:
1281:
1278:
1277:
1273:
1270:
1267:
1266:
1262:
1259:
1256:
1255:
1242:
1239:
1234:
1229:
1224:
1220:
1216:
1213:organisation
1212:
1208:
1203:
1201:
1197:
1193:
1183:
1180:
1173:Executive pay
1170:
1168:
1164:
1159:
1154:
1148:
1144:
1142:
1138:
1137:antitrust law
1134:
1130:
1125:
1123:
1119:
1118:price gouging
1115:
1109:
1106:
1101:
1097:
1092:
1088:
1086:
1082:
1078:
1073:
1069:
1068:
1063:
1057:
1051:
1025:
1020:
1017:
1011:
1006:
1003:
997:
992:
989:
983:
978:
975:
969:
964:Penederm Inc
963:
957:
951:
945:
939:
938:
934:
931:
930:
923:
915:
913:
909:
905:
901:
897:
887:
885:
880:
878:
874:
870:
866:
862:
857:
849:
847:
846:Advair Diskus
843:
839:
829:
827:
825:
820:
810:
807:
803:
801:
797:
792:
790:
780:
778:
771:New COPD drug
768:
766:
761:
751:
749:
739:
736:
734:
730:
729:tax inversion
720:
711:
709:
703:
701:
697:
696:Gayle Manchin
692:
687:
684:
674:
672:
668:
664:
649:
647:
643:
638:
635:
630:
628:
618:
616:
606:
603:
598:
583:
581:
577:
573:
568:
566:
561:
559:
555:
545:
543:
533:
529:
527:
523:
519:
513:
509:
505:
503:
499:
495:
491:
481:
478:
468:
466:
461:
457:
455:
451:
447:
432:
430:
426:
422:
418:
417:ticker symbol
414:
410:
400:
398:
394:
390:
386:
382:
378:
374:
373:West Virginia
370:
360:
358:
357:endocrinology
354:
350:
346:
342:
338:
334:
330:
326:
322:
318:
314:
309:
307:
303:
298:
296:
295:United States
292:
288:
284:
280:
275:
273:
269:
265:
261:
257:
253:
249:
245:
242:was a global
241:
231:
224:
216:
212:
209:
208:
203:
201:
197:
194:
190:
186:
182:
176:
172:
168:
165:
162:
158:
155:
151:
147:
143:
129:
125:
122:
118:
115:
111:
108:
107:United States
104:
92:
88:
85:
82:
78:
72:
69:
65:
61:
57:
53:
50:
45:
41:
36:
30:
19:
5020:
4859:Mallinckrodt
4744:Upsher-Smith
4575:Ortho-McNeil
4306:
4296:
4285:
4275:
4264:
4255:
4243:. Retrieved
4239:
4229:
4217:. Retrieved
4212:
4203:
4191:. Retrieved
4186:
4177:
4165:. Retrieved
4161:
4152:
4140:. Retrieved
4136:
4127:
4115:. Retrieved
4111:
4102:
4090:. Retrieved
4085:
4076:
4064:. Retrieved
4054:
4021:
4017:
3995:
3990:Egan, Matt.
3985:
3973:. Retrieved
3968:
3946:
3937:
3925:. Retrieved
3914:
3903:
3891:
3880:
3853:. Retrieved
3842:
3831:
3821:
3812:
3802:
3792:September 7,
3790:. Retrieved
3779:
3768:
3758:
3747:
3725:The Guardian
3723:
3714:
3703:
3693:
3681:
3670:
3658:
3645:
3635:
3624:
3614:
3603:
3591:
3582:
3572:
3561:
3551:
3542:Ars Technica
3540:
3530:
3519:
3509:
3498:
3471:. Retrieved
3460:
3449:
3425:
3415:
3403:
3392:
3368:
3359:
3347:. Retrieved
3343:the original
3338:
3329:
3317:. Retrieved
3313:
3304:
3294:December 10,
3292:. Retrieved
3288:
3278:
3267:
3257:
3246:
3236:
3224:. Retrieved
3220:
3208:
3200:the original
3193:
3183:
3165:
3147:
3136:
3126:
3115:
3105:
3094:
3082:
3071:
3062:
3051:
3042:
3031:
3022:
3011:
2999:
2988:
2977:
2966:
2954:
2943:
2933:
2922:
2912:
2903:
2893:
2882:
2872:
2861:
2852:
2841:
2831:
2813:
2802:
2792:
2781:
2769:
2758:
2748:
2737:
2716:PBS Newshour
2715:
2705:
2694:
2684:
2675:
2665:
2657:the original
2652:
2643:
2625:
2611:
2600:
2590:
2579:
2569:
2558:
2546:
2535:
2523:
2491:
2482:
2472:September 8,
2470:. Retrieved
2466:the original
2461:
2452:
2441:
2431:
2422:
2413:
2404:
2395:
2383:. Retrieved
2378:
2369:
2354:
2343:
2332:
2320:
2309:
2294:
2283:
2271:
2260:
2236:
2224:
2215:
2206:
2195:
2126:
2122:
2100:
2091:
2082:
2073:
2062:
2050:
2039:
2027:
2016:
2006:
1993:
1965:
1953:
1944:
1934:
1923:
1866:
1862:
1834:
1825:
1808:
1804:
1794:
1785:
1776:
1765:
1732:. Retrieved
1723:
1709:
1689:
1682:
1670:. Retrieved
1666:
1657:
1647:September 8,
1645:. Retrieved
1641:the original
1636:
1609:. Retrieved
1605:
1596:
1584:. Retrieved
1579:
1570:
1558:. Retrieved
1554:
1545:
1533:. Retrieved
1529:
1527:"Mylan N.V."
1521:
1509:. Retrieved
1505:
1496:
1488:the original
1481:
1472:
1460:. Retrieved
1456:the original
1449:
1440:
1429:
1420:
1408:
1398:December 10,
1396:. Retrieved
1382:
1370:
1279:Tetracycline
1211:human rights
1204:
1189:
1176:
1149:
1145:
1132:
1126:
1110:
1104:
1099:
1095:
1093:
1089:
1065:
1059:
932:
921:
893:
881:
858:
855:
835:
823:
816:
808:
804:
793:
786:
774:
757:
745:
737:
726:
717:
704:
688:
682:
680:
660:
639:
631:
624:
612:
594:
569:
567:facilities.
562:
551:
539:
530:
514:
510:
506:
487:
474:
462:
458:
454:penicillin G
446:Milan Puskar
443:
406:
389:Pennsylvania
366:
310:
299:
276:
239:
238:
204:
170:Headquarters
148:merged with
117:Milan Puskar
67:Company type
29:
5051:Parke-Davis
4734:Trevena Inc
4602:Mentholatum
4410:AbbVie Inc.
4352:SEC filings
3788:. Bloomberg
3626:MarketWatch
3226:October 22,
1530:MarketWatch
1462:January 28,
1346:Parkinson's
1231: [
1228:DJE Kapital
1072:anaphylaxis
952:Bertek Inc
708:Joe Manchin
700:Joe Manchin
498:triamterene
496:containing
492:that was a
393:Southpointe
333:dermatology
329:respiratory
317:anaphylaxis
306:S&P 500
264:Netherlands
5153:Categories
5111:ViroPharma
5011:Massengill
4739:Ultragenyx
4470:Bioverativ
4213:Pink Sheet
4187:Pink Sheet
3971:. New York
3927:October 8,
3855:October 1,
3473:August 19,
2101:Pink Sheet
2083:Pink Sheet
1734:August 25,
1555:NASDAQ.com
1375:References
1367:Management
1324:Indication
1304:Antibiotic
1290:Cimetidine
1282:Antibiotic
1271:Antibiotic
1260:Indication
1054:See also:
1048:See also:
1028:(Acq 2016)
1022:(Acq 2016)
1014:(Acq 2014)
1012:Famy Care
1008:(Acq 2014)
1000:(Acq 2013)
994:(Acq 2011)
986:(Acq 2010)
980:(Acq 2007)
972:(Acq 2007)
966:(Acq 1998)
960:(Acq 1996)
954:(Acq 1993)
948:(Acq 1991)
942:(Acq 1989)
627:Merck KGaA
602:Carl Icahn
558:selegiline
542:selegiline
516:it to the
385:Canonsburg
381:Pittsburgh
377:Morgantown
341:anesthesia
337:immunology
291:Merck KGaA
240:Mylan N.V.
207:Operations
137:2020-11-16
54:Mylan N.V.
49:Trade name
33:Mylan N.V.
5061:Qualitest
4931:CancerVax
4714:Sheffield
4704:RespireRx
4699:Regeneron
4550:Intercept
4530:Genentech
4520:Eli Lilly
4505:CytoSport
4495:Ceragenix
3996:CNN Money
3646:Money.com
2904:Bloomberg
2739:USA Today
1611:August 8,
1412:Mylan NV
1081:Medtronic
1039:Criticism
819:valsartan
817:In 2018,
576:lorazepam
532:replace.
450:Don Panoz
308:indices.
200:Divisions
160:Successor
121:Don Panoz
4941:CoTherix
4936:Cephalon
4819:Covidien
4809:Allergan
4799:Alkermes
4719:Spectrum
4587:McKesson
4480:Biovista
4460:BioCryst
4245:July 17,
4219:July 17,
4193:July 17,
4167:July 17,
4142:July 17,
4117:July 17,
4092:July 17,
4066:June 25,
4046:21513100
4038:25344344
3833:NBC News
3650:Archived
3314:BioSpace
2602:CBS News
2334:Barron's
2155:28911475
1817:10118987
1717:. Mylan.
1693:. UPNE.
1586:June 11,
1560:June 11,
1535:June 11,
1511:June 11,
1343:Eldepryl
1245:Products
1238:divested
1215:Reprieve
1122:Medicaid
877:Celebrex
765:Allergan
490:diuretic
313:oncology
304:and the
188:Products
152:to form
113:Founders
80:Industry
59:Formerly
5096:Trubion
4946:Covance
4926:Bradley
4875:, 2013)
4873:Ireland
4869:Perrigo
4865:, 2013)
4863:Ireland
4855:, 2012)
4853:Ireland
4845:, 2014)
4843:Ireland
4835:, 2014)
4833:Ireland
4825:, 2007)
4823:Ireland
4815:, 2015)
4813:Ireland
4805:, 2011)
4803:Ireland
4795:, 2013)
4793:Ireland
4789:Actavis
4759:Viatris
4657:Hospira
4647:Ovation
4642:Organon
4637:NovaBay
4622:Moderna
4560:Ethicon
4490:Century
4475:Biovest
4435:Alnylam
4430:Alexion
4420:Advaxis
4398:Current
4287:Questex
4266:Fortune
4062:. Mylan
3975:May 31,
3969:Reuters
3705:Questex
3563:Science
3521:Gizmodo
3427:Questex
3349:May 11,
3339:Reuters
3319:May 11,
3269:Questex
3195:Reuters
3138:WBOY-TV
3117:Questex
3073:Questex
2945:Fortune
2924:Reuters
2884:Reuters
2804:Questex
2760:Gizmodo
2696:Questex
2492:PM Live
2385:May 31,
2262:Fortune
2146:9345453
1902:Page 50
1841:Reuters
1672:July 1,
1357:Allergy
1332:Maxzide
1209:-based
1196:Alabama
898:via an
873:Lipitor
865:Epi-Pen
861:Viatris
789:Meda AB
748:Perrigo
435:History
383:suburb
289:-based
287:Germany
260:Viatris
244:generic
214:Website
164:Viatris
154:Viatris
135: (
127:Defunct
95: (
90:Founded
5121:Zonite
5101:Upjohn
5036:Nuvelo
5031:Nereus
5026:Naurex
4951:Cubist
4921:Biolex
4906:Amylin
4773:Former
4754:Vertex
4662:Searle
4652:Pfizer
4465:Biogen
4455:Baxter
4162:CIDRAP
4044:
4036:
3451:Forbes
3289:Forbes
2153:
2143:
1896:
1815:
1697:
1354:EpiPen
1207:London
1085:Sanofi
908:NASDAQ
869:Viagra
671:Advair
663:Pfizer
429:NASDAQ
421:NASDAQ
274:, US.
256:Pfizer
252:Upjohn
226:
221:.mylan
150:Upjohn
71:Public
5116:Wyeth
5106:Verus
5086:Tanox
5066:Rib-X
5041:Ortho
5021:Mylan
4976:Genta
4911:ARIAD
4889:Other
4729:Titan
4694:Quark
4540:Ionis
4510:CytRx
4500:Combe
4440:Amgen
4425:Alcon
4340:Mylan
4042:S2CID
3217:(PDF)
2462:Mylan
1360:2007
1349:1989
1338:1984
1307:2004
1296:1994
1293:Ulcer
1285:1968
1274:1966
1235:]
1105:Times
1100:Times
933:Mylan
890:Stock
652:2010s
586:2000s
548:1990s
471:1980s
403:Stock
279:India
62:Milan
4991:King
4986:ISTA
4966:Epix
4916:Barr
4896:Alza
4247:2018
4221:2018
4195:2018
4169:2018
4144:2018
4119:2018
4094:2018
4068:2018
4034:PMID
4022:2014
3977:2017
3929:2016
3857:2016
3794:2016
3475:2016
3351:2020
3321:2020
3296:2019
3228:2020
2474:2016
2423:ICRM
2387:2022
2151:PMID
1997:FDA
1894:ISBN
1813:PMID
1736:2016
1695:ISBN
1674:2018
1649:2016
1613:2018
1588:2018
1562:2018
1537:2018
1513:2018
1464:2010
1400:2020
1321:Name
1257:Name
1019:Meda
875:and
500:and
448:and
343:and
223:.com
205:see
145:Fate
97:1961
93:1961
5091:TAP
5046:OSI
4240:U.S
4026:doi
4018:BMJ
2405:IHS
2216:FTC
2141:PMC
2131:doi
1871:doi
1219:FDA
904:OTC
844:'s
838:FDA
669:'s
413:OTC
219:www
101:in
5155::
4996:KV
4305:.
4284:.
4263:.
4238:.
4211:.
4185:.
4160:.
4135:.
4110:.
4084:.
4040:.
4032:.
4020:.
4016:.
4004:^
3994:.
3967:.
3955:^
3902:.
3879:.
3865:^
3830:.
3811:.
3767:.
3746:.
3734:^
3722:.
3702:.
3669:.
3648:.
3644:.
3623:.
3602:.
3581:.
3560:.
3539:.
3518:.
3497:.
3483:^
3448:.
3436:^
3424:.
3391:.
3377:^
3367:.
3337:.
3312:.
3287:.
3266:.
3245:.
3219:.
3192:.
3135:.
3114:.
3093:.
3070:.
3050:.
3030:.
3010:.
2987:.
2965:.
2942:.
2921:.
2902:.
2881:.
2860:.
2840:.
2801:.
2780:.
2757:.
2736:.
2724:^
2714:.
2693:.
2674:.
2651:.
2599:.
2578:.
2557:.
2534:.
2500:^
2490:.
2460:.
2440:.
2421:.
2403:.
2377:.
2359:.
2353:.
2331:.
2308:.
2282:.
2259:.
2247:^
2235:.
2214:.
2194:.
2180:^
2163:^
2149:.
2139:.
2127:23
2125:.
2121:.
2109:^
2099:.
2081:.
2061:.
2038:.
2015:.
1976:^
1964:.
1943:.
1922:.
1908:^
1900:.
1885:^
1865:.
1861:.
1849:^
1839:.
1833:.
1807:.
1803:.
1784:.
1764:.
1744:^
1665:.
1635:.
1621:^
1604:.
1578:.
1553:.
1504:.
1480:.
1448:.
1428:.
1391:.
1233:de
879:.
871:,
867:,
848:.
431:.
399:.
387:,
371:,
351:,
347:,
339:,
335:,
331:,
327:,
323:,
319:,
315:,
254:,
178:,
105:,
4871:(
4861:(
4851:(
4841:(
4831:(
4821:(
4811:(
4801:(
4791:(
4383:e
4376:t
4369:v
4311:.
4290:.
4269:.
4249:.
4223:.
4197:.
4171:.
4146:.
4121:.
4096:.
4070:.
4048:.
4028::
3998:.
3979:.
3949:.
3931:.
3908:.
3885:.
3859:.
3836:.
3815:.
3796:.
3773:.
3752:.
3708:.
3675:.
3629:.
3608:.
3585:.
3566:.
3545:.
3524:.
3503:.
3477:.
3454:.
3430:.
3397:.
3353:.
3323:.
3298:.
3272:.
3251:.
3230:.
3141:.
3120:.
3099:.
3016:.
2971:.
2948:.
2927:.
2906:.
2887:.
2846:.
2807:.
2786:.
2763:.
2742:.
2718:.
2699:.
2678:.
2619:.
2605:.
2584:.
2563:.
2540:.
2476:.
2446:.
2425:.
2389:.
2337:.
2314:.
2288:.
2265:.
2241:.
2200:.
2174:.
2157:.
2133::
2067:.
2044:.
2021:.
1970:.
1947:.
1928:.
1879:.
1873::
1867:3
1819:.
1809:8
1788:.
1770:.
1738:.
1703:.
1676:.
1651:.
1615:.
1590:.
1564:.
1539:.
1515:.
1466:.
1402:.
824:N
139:)
99:)
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.